Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pathol Res Pract ; 197(8): 569-76, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11518051

RESUMEN

Aggressive osteoblastoma is a rare bone-forming neoplasm composed of prominent epithelioid cells that demonstrate locally invasive growth with a high rate of recurrence but no metastatic potential. Clinical, radiographic and pathologic features of mandibular aggressive osteoblastoma in a 21-year-old African-American male and a 12-year-old Caucasian female are presented. Both tumors were resected with wide surgical margins and neither patient had adjuvant radiation or chemotherapy. The patients showed no evidence of local recurrence or distant spread either clinically or radiographically after two years of follow-up. These tumors were composed of solid sheets of pleomorphic epithelioid cells, eosinophilic amorphous osteoid with foci of calcification, which closely simulated amyloid. Differentiation of this tumor from histologically similar calcifying epithelial odontogenic tumor and low-grade osteosarcoma proved difficult. Immunohistochemical study with osteocalcin confirmed the osteoblastic nature of these epithelioid cells.


Asunto(s)
Ameloblastoma/patología , Neoplasias Mandibulares/patología , Osteoblastoma/patología , Adulto , Biomarcadores de Tumor/análisis , Niño , Diagnóstico Diferencial , Células Epitelioides/patología , Femenino , Humanos , Inmunohistoquímica , Masculino , Neoplasias Mandibulares/química , Neoplasias Mandibulares/diagnóstico por imagen , Neoplasias Mandibulares/cirugía , Osteoblastoma/química , Osteoblastoma/diagnóstico por imagen , Osteoblastoma/cirugía , Osteoblastos/patología , Osteocalcina/análisis , Radiografía , Vimentina/análisis
2.
J Med Chem ; 43(19): 3573-6, 2000 Sep 21.
Artículo en Inglés | MEDLINE | ID: mdl-11000012

RESUMEN

Heparin is the anticoagulant of choice for hospitalized patients, but it is dosed only by injection because it is not absorbed following oral administration. We have discovered and prepared compounds (delivery agents) that facilitate the gastrointestinal absorption of heparin in rats, monkeys, and humans when given orally. We are currently developing a parallel synthesis approach to increase our delivery agent screening throughput in vivo. This approach has been used to produce micromolar quantities of compounds for testing in rats in a 5 x 5 parallel synthesis array. Using an amine benzoylation reaction sequence, 10 mixtures were prepared. These mixtures contained equal weight quantities of five N-substituted, non-alpha, amino acid delivery agents. Each of these mixtures was orally administered to rats in combination with heparin, and plasma clotting times (APTT) were measured to determine activity. Deconvolution of the data accurately identified the most active individual components. Independent synthesis of these compounds verified their activity. This parallel synthesis approach is an effective tool for the screening of oral heparin delivery agents and has increased screening throughput significantly.


Asunto(s)
Aminoácidos/síntesis química , Anticoagulantes/administración & dosificación , Portadores de Fármacos/síntesis química , Evaluación Preclínica de Medicamentos/métodos , Heparina/administración & dosificación , Animales , Cromatografía Líquida de Alta Presión , Colon , Espectroscopía de Resonancia Magnética , Masculino , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA